Modulation of cytotoxic T lymphocyte, natural killer cell, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by Vernonia cinerea L. and vernolide-A in BALB/c mice via enhanced production of cytokines IL-2 and IFN-γ

References

• Hersh, E., Freireich, E. (1968) Methods in cancer research. New York: Academic Press.
   Google Scholar
• Yang, X., Guo, D., Zhang, J., Wu, M. Characterization and anti-tumor activity of pollen polysaccharide. Int Immunopharmacol 2007, 7, 401–408.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya, N., Pal, A., Patra, S., Haldar, A.K., Roy, S., Ray, M. Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host. Int Immunopharmacol 2008, 8, 1503–1512.
   PubMed Web of Science ®Google Scholar
• Kanagawa, N., Niwa, M., Hatanaka, Y., Tani, Y., Nakagawa, S., Fujita, T., Yamamoto, A., Okada, N. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int J Cancer 2007, 121, 2013–2022.
   PubMed Web of Science ®Google Scholar
• Gao, J.Q., Tsuda, Y., Han, M., Xu, D.H., Kanagawa, N., Hatanaka, Y., Tani, Y., Mizuguchi, H., Tsutsumi, Y., Mayumi, T., Okada, N., Nakagawa, S. NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy. Cancer Immunol Immunother 2009, 58, 291–299.
   PubMed Web of Science ®Google Scholar
• Leong, S.P. Immunotherapy of malignant melanoma. Surg Clin North Am 1996, 76, 1355–1381.
   PubMed Web of Science ®Google Scholar
• Cooper, M.A., Fehniger, T.A., Caligiuri, M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22, 633–640.
   PubMed Web of Science ®Google Scholar
• Robertson, M.J., Ritz, J. Biology and clinical relevance of human natural killer cells. Blood 1990, 76, 2421–2438.
   PubMed Web of Science ®Google Scholar
• Terlikowski, S.J. Local immunotherapy with rhTNF-α mutein induces strong antitumor activity without overt toxicity–a review. Toxicology 2002, 174, 143–152.
   PubMed Web of Science ®Google Scholar
• Misawa, E., Sakurai, T., Yamada, M., Hayasawa, H., Motoyoshi, K. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1(+) cells in mice. Int J Immunopharmacol 2000, 22, 967–977.
   PubMed Web of Science ®Google Scholar
• Goldsmith, M., Greene, W. (1994). Interleukin-2 and the interleukin-2 receptor complex. Norfolk, England: Paston Press Ltd.
   Google Scholar
• Ognibene, F.P., Rosenberg, S.A., Lotze, M., Skibber, J., Parker, M.M., Shelhamer, J.H., Parrillo, J.E. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 1988, 94, 750–754.
   PubMed Web of Science ®Google Scholar
• Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., Weber, J.S., Parkinson, D.R., Seipp, C.A., Einhorn, J.H., White, D.E. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 1994, 271, 907–913.
   PubMed Web of Science ®Google Scholar
• Billiau, A., Vandenbroeck, K. (2001). Interferon-γ. In Oppenheim, J., Feldmann, M, eds. Cytokine reference. San Diego: Academic Press, 641–688.
   Google Scholar
• Fidler, I., Poste, G. (1985). Immunomodulation of macrophages for cancer and antiviral therapy. In Tomlinson, I., Davis, S. eds. Site specific drug delivery. New York: Wiley, 111–135.
   Google Scholar
• Agarwal, S., Singh, V. Immunomodulators: A review of studies on Indian medicinal plants and synthetic peptides: Part I. Medicinal Plants 1999, 179–204.
   Google Scholar
• Manu, K.A., Kuttan, G. Immunomodulatory activities of Punarnavine, an alkaloid from Boerhaavia diffusa. Immunopharmacol Immunotoxicol 2009, 31, 377–387.
   PubMed Web of Science ®Google Scholar
• Manu, K.A., Kuttan, G. Boerhaavia diffusa stimulates cell-mediated immune response by upregulating IL-2 and downregulating the pro-inflammatory cytokines and GM-CSF in B16F-10 metastatic melanoma bearing mice. J Exp Ther Oncol 2008, 7, 17–29.
   PubMedGoogle Scholar
• Manu, K.A., Kuttan, G. Effect of Punarnavine, an alkaloid from Boerhaavia diffusa, on cell-mediated immune responses and TIMP-1 in B16F-10 metastatic melanoma-bearing mice. Immunopharmacol Immunotoxicol 2007, 29, 569–586.
   PubMed Web of Science ®Google Scholar
• Sheeja, K., Kuttan, G. Andrographis paniculata downregulates proinflammatory cytokine production and augments cell mediated immune response in metastatic tumor-bearing mice. Asian Pac J Cancer Prev 2010, 11, 723–729.
   PubMed Web of Science ®Google Scholar
• Sheeja, K., Kuttan, G. Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide. Immunopharmacol Immunotoxicol 2007, 29, 81–93.
   PubMed Web of Science ®Google Scholar
• Sheeja, K., Kuttan, G. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr Cancer Ther 2007, 6, 66–73.
   PubMed Web of Science ®Google Scholar
• Kumar, P.P., Kuttan, G. Vernonia cinerea L. scavenges free radicals and regulates nitric oxide and proinflammatory cytokines profile in carrageenan induced paw edema model. Immunopharmacol Immunotoxicol 2009, 31, 94–102.
   PubMed Web of Science ®Google Scholar
• Pratheeshkumar, P., Kuttan, G. Modulation of immune response by Vernonia cinerea L. inhibits the proinflammatory cytokine profile, iNOS, and COX-2 expression in LPS-stimulated macrophages. Immunopharmacol. Immunotoxicol 2010, 1–11.
   Web of Science ®Google Scholar
• Pratheeshkumar, P., Kuttan, G. Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice. Inflammopharmacology 2010, 1–11.
   Google Scholar
• Pratheeshkumar, P., Kuttan, G. Vernonia cinerea Less. Inhibits Tumor Cell Invasion and Pulmonary Metastasis in C57BL/6 Mice. Integr Cancer Ther 2010, <Volume>.
   PubMed Web of Science ®Google Scholar
• Kuo, Y.H., Kuo, Y.J., Yu, A.S., Wu, M.D., Ong, C.W., Yang Kuo, L.M., Huang, J.T., Chen, C.F., Li, S.Y. Two novel sesquiterpene lactones, cytotoxic vernolide-A and -B, from Vernonia cinerea. Chem Pharm Bull 2003, 51, 425–426.
   PubMed Web of Science ®Google Scholar
• Chea, A., Hout, S., Long, C., Marcourt, L., Faure, R., Azas, N., Elias, R. Antimalarial activity of sesquiterpene lactones from Vernonia cinerea. Chem Pharm Bull 2006, 54, 1437–1439.
   PubMed Web of Science ®Google Scholar
• Chen, X., Zhan, Z.J., Yue, J.M. Sesquiterpenoids from Vernonia cinerea. Nat Prod Res 2006, 20, 31–35.
   PubMed Web of Science ®Google Scholar
• Kim, Y.B., Huh, N.D., Koren, H.S., Amos, D.B. Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germfree piglets. I. Comparison of NK and ADCC. J Immunol 1980, 125, 755–762.
   PubMed Web of Science ®Google Scholar
• Gupta, S., Bhattacharya, B. (1983). Cytotoxicity assays. In Talwar, G.P., ed. A handbook of practical immunology. New Delhi: Vikas Publishing House, 328–333.
   Google Scholar
• Kobayashi, H., Aso, H., Ishida, N., Maeda, H., Schmitt, D.A., Pollard, R.B., Suzuki, F. Preventive effect of a synthetic immunomodulator, 2-carboxyethylgermanium sesquioxide, on the generation of suppressor macrophages in mice immunized with allogeneic lymphocytes. Immunopharmacol Immunotoxicol 1992, 14, 841–864.
   PubMed Web of Science ®Google Scholar
• Manesh, C., Kuttan, G. Effect of naturally occurring isothiocyanates on the immune system. Immunopharmacol Immunotoxicol 2003, 25, 451–459.
   PubMed Web of Science ®Google Scholar
• Kempf, R.A., Mitchell, M.S. Effects of chemotherapeutic agents on the immune response. II. Cancer Invest 1985, 3, 23–33.
   PubMed Web of Science ®Google Scholar
• Santin, A.D., Hermonat, P.L., Ravaggi, A., Bellone, S., Roman, J., Pecorelli, S., Cannon, M., Parham, G.P. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 2000, 48, 997–1006.
   PubMed Web of Science ®Google Scholar
• Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 2002, 87, 21–27.
   PubMed Web of Science ®Google Scholar
• Gross, S., Walden, P. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer. Immunol Lett 2008, 116, 7–14.
   PubMed Web of Science ®Google Scholar
• Kim, K.D., Choi, S.C., Kim, A., Choe, Y.K., Choe, I.S., Lim, J.S. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction. Int Immunopharmacol 2001, 1, 2117–2129.
   PubMed Web of Science ®Google Scholar
• Shan, Y., Sugiura, Y. Suppressive effect of Chinese medicinal herb, Acanthopanax gracilistylus, extract on human lymphocytes in vitro. Clin Exp Immunol 1999, 118, 41–48.
   PubMed Web of Science ®Google Scholar
• Ahmad, A., Menezes, J. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J 1996, 10, 258–266.
   PubMed Web of Science ®Google Scholar
• Boon, T., Coulie, P.G., Van den Eynde, B.J., van der Bruggen, P. Human T cell responses against melanoma. Annu Rev Immunol 2006, 24, 175–208.
   PubMed Web of Science ®Google Scholar
• Zitvogel, L., Tesniere, A., Kroemer, G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006, 6, 715–727.
   PubMed Web of Science ®Google Scholar
• Farrar, W.L., Mizel, S.B., Farrar, J.J. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. J Immunol 1980, 124, 1371–1377.
   PubMed Web of Science ®Google Scholar
• Siegel, J.P. Effects of interferon-gamma on the activation of human T lymphocytes. Cell Immunol 1988, 111, 461–472.
   PubMed Web of Science ®Google Scholar
• GORER, P.A. Studies in antibody response of mice to tumour inoculation. Br J Cancer 1950, 4, 372–379.
   PubMed Web of Science ®Google Scholar
• Win, S., Uenaka, A., Nakayama, E. Immune responses against allogeneic and syngeneic tumors in aged C57BL/6 mice. Microbiol Immunol 2002, 46, 513–519.
   PubMed Web of Science ®Google Scholar
• Asano, Y., Kaneda, K., Hiragushi, J., Tsuchida, T., Higashino, K. The tumor-bearing state induces augmented responses of organ-associated lymphocytes to high-dose interleukin-2 therapy in mice. Cancer Immunol Immunother 1997, 45, 63–70.
   PubMed Web of Science ®Google Scholar
• Caligiuri, M.A., Murray, C., Robertson, M.J., Wang, E., Cochran, K., Cameron, C., Schow, P., Ross, M.E., Klumpp, T.R., Soiffer, R.J. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest 1993, 91, 123–132.
   PubMed Web of Science ®Google Scholar
• Henney, C., Kuribayashi, K., Kern, D., Gillis, S. Interleukin-2 augments natural killer cell activity. Nature 1981, 291, 335–338.
   PubMed Web of Science ®Google Scholar
• Ehrhardt, R.O., Lúdvíksson, B.R., Gray, B., Neurath, M., Strober, W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 1997, 158, 566–573.
   PubMed Web of Science ®Google Scholar